Chromate
USA-based analytical-services provider with a public Verify portal and a stated focus on independent supplement and research testing.
This label reflects how the provider presents itself on its own site today, not a formal accreditation category.
Whether the site appears to invite direct sample submission from individuals rather than only business or institutional clients.
Whether the provider appears to offer public-facing report publishing, result browsing, or direct verification tooling.
This is our shorthand for how visible the provider's result or verification layer appears to be, ranging from none to searchable public verification.
Location details are kept conservative and only shown when clearly supported by the source page or the provider’s public materials.
What we can verify now
Chromate publicly presents itself as a U.S.-based analytical-services provider with a Verify portal for test results and a separate Chromate Testing Project focused on unannounced testing.
The official site clearly states:
- the lab is based in the United States
- samples can be sent in for analysis
- results are made available through the site’s Verify portal
- and the lab positions itself around independent analysis and manufacturer accountability
Coverage notes
- This is a real enough public verification pattern to justify a live testing profile
- Direct-consumer intake is still not explicit enough to mark as confirmed
Yes - Peptide Partners’ public certification archive currently provides one of the strongest visible cross-links tying Chromate into the peptide-vendor ecosystem
Why it matters in the current ecosystem
Chromate matters because it helps round out the multi-lab side of the provider graph.
In the current PeptideBenchmark system, its importance comes less from broad recurring vendor density and more from being one of the named outside labs that shows up inside a deeper public archive context. That makes it useful for readers trying to understand how multi-lab vendor programs are structured rather than assuming every provider relationship is a live direct-verify workflow.
What to watch for
Chromate’s current public role is still narrower than the top anchors.
It appears to have a real verification surface, but the peptide-specific public trail we can currently inspect is still relatively thin outside of the strongest archive-driven cross-links. So readers should view it as a credible named lab node, not yet as one of the dominant trust-system hubs.